hepatitis a virus, strain hm175 inactivated

Poland

Drugs containing this active substance

  • HAVRIX 720 JUNIOR

    It is used to prevent hepatitis A (HAV) in individuals from 1 year of age up to and including 15 years, and if necessary, also in adolescents aged 16 to 18 years.

    Form: suspension for injection

    Active substance Dosage
    hepatitis a virus, strain hm175 inactivated not less than 720 ELISA units

    ATC: J07BC02

    Manufacturer: GlaxoSmithKline Biologicals S.A.

  • HAVRIX ADULT

    It is used to prevent hepatitis A (HAV) in individuals over 16 years of age who are at risk of infection with this virus.

    Form: suspension for injection

    Active substance Dosage
    hepatitis a virus, strain hm175 inactivated not less than 1440 ELISA units

    ATC: J07BC02

    Manufacturer: GlaxoSmithKline Biologicals S.A.